NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
Diffuse alveolar hemorrhage associated with E-VALI: literature review and report of a case in Mexico

López-Fermín, Jorge1,2; Pérez-Nieto, Orlando Rubén1,2; Deloya-Tomas, Ernesto1,2; Carrión-Moya, Jorge1; Castillo-Gutiérrez, Gabriela1; Olvera-Ramos, María Guadalupe1; de la Torre-Rittscher, Andrea Guadalupe1; Mondragón-Labelle, Tania Olga1; Pozos-Cortés, Karen Pamela1; Trejo-Osornio, David Alejandro1; Zamarrón-López, , Eder Iván2,3; Secchi-del Río, Roberto1





2020, Number 4

2020; 79 (4)






ABSTRACT

In the last decade, the use of e-cigarettes in Mexico has increased indiscriminately. Recently the association between the use of vaporizers, commonly called "vaping" and lung lesions, has been reported. Lung injury associated with the use of e-cigarettes (E-VALI) poses a life threat, regardless of frequency or intensity. It is necessary to suspect E-VALI as a differential diagnosis in patients with respiratory failure without apparent etiology who have the history of e-cigarette use. The Centers for Disease Control and Prevention (CDC) states that, in the background of e-cigarette exposure and the exclusion of common differential diagnoses (infectious, neoplastic, rheumatological processes, etc.), the possibility of E-VALI is confirmed. Early diagnosis and appropriate therapeutics for this pathology are essential. We present the approach of a 26-year-old male patient with diffuse alveolar haemorrhage associated with E-VALI and an updated review of the subject.

KEYWORDS

Electronic cigarettes, E-VALI, acute respiratory distress syndrome, diffuse alveolar hemorrhage, vaping associated lung injury.

REFERENCES

  1. Boudi FB, Patel S, Boudi A, Chan C. Vitamin E acetate as a plausible cause of acute vaping-related illness. Cureus. 2019;11(12):e6350. https://doi.org/10.7759/cureus.6350.

  2. Heinzerling A, Armatas C, Karmarkar E, Attfield K, Guo W, Wang Y, et al. Severe lung injury associated with use of e-cigarette, or vaping, products-California, 2019. JAMA Intern Med. 2020;180(6):861-869. https://doi.org/10.1001/jamainternmed.2020.0664.

  3. Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L193-L206. https://doi.org/10.1152/ajplung.00071.2017.

  4. Davidson K, Brancato A, Heetderks P, Mansour W, Matheis E, Nario M, et al. Outbreak of electronic-cigarette-associated acute lipoid pneumonia - North Carolina, July-August 2019. MMWR Morb Mortal Wkly Rep. 2019;68(36):784-786. https://doi.org/10.15585/mmwr.mm6836e1.

  5. Lilly CM, Khan S, Waksmundzki-Silva K, Irwin RS. Vaping-Associated respiratory distress syndrome: Case classification and clinical guidance. Crit Care Explor. 2020;2(2):e0081. https://doi.org/10.1097/cce.0000000000000081.

  6. Blount BC, Karwowski MP, Shields PG. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med. 2020;382(8):697-705. doi:10.1056/NEJMoa1916433.

  7. NIDA. Cigarrillos electrónicos (e-cigs) – DrugFacts. National Institute on Drug Abuse. [Internet 16 Jan. 2020. Available from: https://www.drugabuse.gov/es/publicaciones/drugfacts/cigarrillos-electronicos-e-cigs.

  8. Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco, ENCODAT 2016-2017. Disponible en: https://www.gob.mx/salud%7Cconadic/acciones-y-programas/encuesta-nacional-de-consumo-de-drogas-alcohol-y-tabaco-encodat-2016-2017-136758.

  9. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141(6):1400-1406. https://doi.org/10.1378/chest.11-2443.

  10. Posicionamiento respecto al cigarro electrónico y otros SEAN, Ciudad de México; Gobierno de México; 2019. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/498137/AE_Vapeo_25092019.pdf.

  11. Drope J, Cahn Z, Kennedy R, Liber AC, Stoklosa M, Henson R, et al. Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine. CA Cancer J Clin. 2017;67(6):449-471. https://doi.org/10.3322/caac.21413.

  12. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin-Final report. N Engl J Med. 2020;382(10):903-916. https://doi.org/10.1056/nejmoa1911614,

  13. Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019;366:l5275. https://doi.org/10.1136/bmj.l5275.

  14. Triantafyllou GA, Tiberio PJ, Zou RH, Lamberty PE, Lynch MJ, Kreit JW, et al. Vaping-associated acute lung injury: a case series. Am J Respir Crit Care Med. 2019;200(11):1430-1431. https://doi.org/10.1164/rccm.201909-1809le.

  15. Fryman C, Lou B, Weber AG, Steinberg HN, Khanijo S, Iakovou A, et al. Acute respiratory failure associated with vaping. Chest. 2020;157(3):e63-e68. https://doi.org/10.1016/j.chest.2019.10.057.

  16. Chand HS, Muthumalage T, Maziak W, Rahman I. Pulmonary toxicity and the pathophysiology of electronic cigarette, or vaping product, use associated lung injury. Front Pharmacol. 2020;10:1619. doi: 10.3389/fphar.2019.01619.

  17. Blagev DP, Harris D, Dunn AC, Guidry DW, Grissom CK, Lanspa MJ. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Lancet. 2019;394(10214):2073-2083. https://doi.org/10.1016/s0140-6736(19)32679-0

  18. Henry TS, Kligerman SJ, Raptis CA, Mann H, Sechrist JW, Kanne JP. Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol. 2020;214(3):498-505. https://doi.org/10.2214/ajr.19.22251

  19. Larsen BT, Butt YM, Smith ML. More on the pathology of vaping-associated lung injury. Reply. N Engl J Med. 2020;382(4):388-390. https://doi.org/10.1056/nejmc1914980.

  20. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, et al. Pulmonary lipid-laden macrophages and vaping. N Engl J Med. 2019;381(15):1488-1489. https://doi.org/10.1056/nejmc1912038.

  21. Ghinai I, Pray IW, Navon L, O'Laughlin K, Saathoff-Huber L, Hoots B, et al. E-cigarette product use, or vaping, among persons with associated lung injury - Illinois and Wisconsin, April-September 2019. MMWR Morb Mortal Wkly Rep. 2019;68(39):865-869. https://doi.org/10.15585/mmwr.mm6839e2.

  22. Butt YM, Smith ML, Tazelaar HD, Vaszar LT, Swanson KL, Cecchini MJ, et al. Pathology of vaping-associated lung injury. N Engl J Med. 2019;381(18):1780-1781.https://doi.org/10.1056/nejmc1913069.

  23. Hartnett KP, Kite-Powell A, Patel MT, Haag BL, Sheppard MJ, Dias TP, et al. Syndromic surveillance for e-cigarette, or vaping, product use-associated lung injury. N Engl J Med. 2020;382(8):766-772. https://doi.org/10.1056/nejmsr1915313.

  24. Thirión-Romero I, Rodríguez-Llamazares S, Terán-De la Sancha K, González-Woge M, Pérez-Padilla R. Daño pulmonar grave en vapeadores. Neumol Cir Torax. 2019;78(4):340-341. dx.doi.org/10.35366/NT194A.

  25. Chatham-Stephens K, Roguski K, Jang Y, Cho P, Jatlaoui TC, Kabbani S, et al. Characteristics of hospitalized and nonhospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury - United States, November 2019. MMWR Morb Mortal Wkly Rep. 2019;68(46):1076-1080. https://doi.org/10.15585/mmwr.mm6846e1.


2020, Number 4

2020; 79 (4)